Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2025-12-24 @ 5:05 PM
NCT ID:
NCT04356950
Eligibility Criteria:
Inclusion Criteria:
* Patient with SARS-CoV-2 infection entering hospitalization with or without resuscitation
* The patient (or their carer) must have given their free and informed consent and signed the consent form
* The patient must be a member or beneficiary of a health insurance plan
Exclusion Criteria:
* Pregnant or breastfeeding patient
* It is impossible to give the subject informed information
* The patient is under safeguard of justice or state guardianship
* Thrombotic events during treatment: flare-up of venous thromboembolism, flare-up of atherothrombosis.
* Long-term anticoagulant treatment (anti-vitamin K, direct oral anticoagulant).
* Chronic anti-aggregation treatment.
* Pre-existing constitutive or acquired known coagulation pathology: hemorrhagic diseases (thrombocytopenia, thrombocytopathy, hemophilia, von Willebrand's disease, hemorrhagiparous factor deficiency), and for thrombophilia (deficits in antithrombin, protein C or S , Factor V Leiden or Prothrombin 20201A mutation).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04356950
Study Brief:
Protocol Section:
NCT04356950